Taiho Oncologyincis A U Ssubsidiary Of Taiho Pharmaceutical Co Ltd Which Is Part Of Otsuka Holdings Co Ltdbased In Princetonnew Jerseythe Company Serves As The North American Oncology Commercial Organization For Otsuka Pharmaceuticals And Also Manages Operations In Europe And Canada The Mission Of Taiho Oncology Is To Enhance The Lives Of Cancer Patientstheir Familiesand Caregiversthe Company Specializes In Developing And Marketing Orally Administered Anti Cancer Agents For Various Tumor Typesits Product Lineup Includes Notable Drugs Such As Futrafuluftts 1And Uzelwhich Have Contributed To Advancements In Outpatient Cancer Therapytaiho Oncology Is Supported By A Global Network Of Over 168 Companiesemploying More Than 34 400 Peoplewhich Aids In Its Commitment To Improving Global Health
